A comprehensive mapping of thymosin β4 and β10 expression across human organs from fetal development through adulthood reveals age- and tissue-specific patterns that help explain these peptides' diverse roles in health and disease.
The 'β-thymosin enigma'How two small, structurally simple peptides (Tβ4 and Tβ10) can perform such diverse functions across so many organs throughout human development
What the researchers found
This review maps how thymosin β4 and thymosin β10 are expressed across human organs throughout development — from fetal stages through different ages after birth. The research group used proteomics (on preterm newborn saliva and gingival fluid) and immunohistochemistry (on autopsy tissues from fetuses and adults) to track these two peptides over time and across tissues.
Key discoveries include that β-thymosins are expressed in organ-specific and age-dependent patterns, with important implications for understanding their roles in development and disease. The review addresses the 'β-thymosin enigma' — the puzzle of how these small, seemingly simple peptides can have such diverse biological functions across so many tissues, including roles in carcinogenesis.
Why it matters
Thymosin β4 is one of the most studied peptides in regenerative medicine, yet its fundamental biology during human development remains poorly mapped. Understanding when and where β-thymosins are expressed during organ formation helps explain both their therapeutic potential and their involvement in diseases like cancer. The developmental expression patterns could reveal new therapeutic windows and targets.
The numbers in context
Thymosin β4 and β10 studied · Multiple human organs and tissues · Fetal through adult ages · Proteomics + immunohistochemistry methods · Preterm newborn saliva studied · Autopsy tissue analysis
How the study worked
The review summarizes the group's multi-year research program using two approaches: (1) proteomics analysis of saliva from preterm newborns and gingival crevicular fluid to identify β-thymosin expression, and (2) immunohistochemistry on autopsy tissues from human fetuses at different gestational ages and adults to map β-thymosin distribution across organs.
Who was studied
Not applicable (review of studies on human fetal and adult organ tissues from autopsies, plus preterm newborn saliva samples)
What this study cannot tell us
The review primarily summarizes work from a single research group, which may reflect a particular methodological perspective. Autopsy tissues may not perfectly represent in vivo expression due to post-mortem changes. The abstract doesn't detail which specific organs were studied or provide quantitative expression data. Immunohistochemistry detects protein presence but doesn't precisely quantify levels.
How to read the evidence
This is a review primarily summarizing one research group's program of proteomics and immunohistochemistry studies. It provides descriptive tissue-mapping data rather than clinical or therapeutic findings.
When this study was published
Published in 2024, this review integrates years of developmental expression research into a current synthesis. It reflects the most recent understanding of β-thymosin biology during human organ development.
The bigger picture
Thymosin β4 has been investigated as a therapeutic for corneal wounds, cardiac injury, and neurological damage. Understanding its natural expression patterns during development helps contextualize why it works in some tissues but not others, and why it may contribute to cancer progression in certain settings. This developmental mapping is essential groundwork for the rational development of β-thymosin-based therapies.
Questions still open
- Do the developmental expression patterns of Tβ4 predict which adult tissues respond best to exogenous thymosin β4 treatment?
- Is the involvement of β-thymosins in carcinogenesis related to reactivation of fetal expression patterns in adult tissues?
- Could differences between Tβ4 and Tβ10 expression patterns explain their potentially distinct biological roles?
Common questions
What is the 'β-thymosin enigma'?
Why does it matter where thymosins are expressed during fetal development?
Read the original research
Thymosin β4 and β10 Expression in Human Organs during Development: A Review.
Cells, 13(13)
Citation
Faa, Gavino; Messana, Irene; Coni, Pierpaolo; Piras, Monica; Pichiri, Giuseppina; Piludu, Marco; Iavarone, Federica; Desiderio, Claudia; Vento, Giovanni; Tirone, Chiara; Manconi, Barbara; Olianas, Alessandra; Contini, Cristina; Cabras, Tiziana; Castagnola, Massimo. (2024). Thymosin β4 and β10 Expression in Human Organs during Development: A Review.. Cells, 13(13). https://doi.org/10.3390/cells13131115